Literature DB >> 15244248

Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood.

Agnieszka Szuster-Ciesielska1, Elzbieta Hryciuk-Umer, Andrzej Stepulak, Krzysztof Kupisz, Martyna Kandefer-Szerszeń.   

Abstract

Squamous cell carcinoma of the head and neck is a devastating illness with a severe impact on affected individuals. Several mechanisms may lead to oxidative stress in tumor-bearing patients, among others chronic inflammation. Inflammatory cells, especially macrophages and neutrophil leukocytes, may produce reactive oxygen species (ROS) which participate in carcinogenesis and tumor-associated immunosuppression. The aim of the study presented in this paper was to compare the production of reactive oxygen species (ROS)--superoxide anion (O2-) and hydrogen peroxide (H2O2)--by neutrophils isolated from the blood of 16 patients with larynx carcinoma and 15 healthy controls. The serum activity of superoxide dismutase and catalase as well as the total peroxidase activity in serum have also been estimated. The production of ROS, especially spontaneous and phorbol 12-myristate 13-acetate (PMA)-induced O2-, was relatively higher in the patients with larynx carcinoma than in the healthy controls and increased parallel with the tumor stage (tumor, node, metastasis-TNM staging). The serum activity of catalase and peroxidase was also highest in the patients with stage T3 and T4 larynx carcinoma. After partial or total laryngectomy, a significant decrease in ROS production and the serum activity of catalase and peroxidase was observed. In contrast, the serum level of superoxide dismutase, which had been low prior to surgery, especially in the patients with advanced tumor stages (T3-T4), increased significantly afterwards. The results indicate the existence of oxidative stress in the blood of patients with larynx carcinoma and its significant decrease after partial or total laryngectomy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15244248     DOI: 10.1080/02841860410029708

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  18 in total

Review 1.  Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Semin Cancer Biol       Date:  2012-01-31       Impact factor: 15.707

2.  Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β.

Authors:  Jessica L Rastad; William R Green
Journal:  Virology       Date:  2016-09-12       Impact factor: 3.616

Review 3.  Myeloid-derived suppressor cells: natural regulators for transplant tolerance.

Authors:  Peter Boros; Jordi C Ochando; Shu-Hsia Chen; Jonathan S Bromberg
Journal:  Hum Immunol       Date:  2010-08-10       Impact factor: 2.850

4.  High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma.

Authors:  Richard Salzman; Lukáš Pácal; Kateřina Kaňková; Josef Tomandl; Zuzana Horáková; Eva Tóthová; Rom Kostřica
Journal:  Int J Clin Oncol       Date:  2010-07-15       Impact factor: 3.402

5.  Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

Authors:  Guocan Wang; Xin Lu; Prasenjit Dey; Pingna Deng; Chia Chin Wu; Shan Jiang; Zhuangna Fang; Kun Zhao; Ramakrishna Konaparthi; Sujun Hua; Jianhua Zhang; Elsa M Li-Ning-Tapia; Avnish Kapoor; Chang-Jiun Wu; Neelay Bhaskar Patel; Zhenglin Guo; Vandhana Ramamoorthy; Trang N Tieu; Tim Heffernan; Di Zhao; Xiaoying Shang; Sunada Khadka; Pingping Hou; Baoli Hu; Eun-Jung Jin; Wantong Yao; Xiaolu Pan; Zhihu Ding; Yanxia Shi; Liren Li; Qing Chang; Patricia Troncoso; Christopher J Logothetis; Mark J McArthur; Lynda Chin; Y Alan Wang; Ronald A DePinho
Journal:  Cancer Discov       Date:  2015-12-23       Impact factor: 39.397

Review 6.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

Review 7.  The role of myeloid-derived suppressor cells in gastrointestinal cancer.

Authors:  Cheng Cui; Penglin Lan; Li Fu
Journal:  Cancer Commun (Lond)       Date:  2021-03-27

8.  Characteristics of "Tip-DCs and MDSCs" and Their Potential Role in Leishmaniasis.

Authors:  Maximilian Schmid; Anja K Wege; Uwe Ritter
Journal:  Front Microbiol       Date:  2012-03-12       Impact factor: 5.640

9.  Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance.

Authors:  Nahzli Dilek; Romain Vuillefroy de Silly; Gilles Blancho; Bernard Vanhove
Journal:  Front Immunol       Date:  2012-07-17       Impact factor: 7.561

10.  Myeloid derived suppressor cells: Targets for therapy.

Authors:  Todd J Waldron; Jon G Quatromoni; Tatiana A Karakasheva; Sunil Singhal; Anil K Rustgi
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.